Bio15Pharma

Who are we

Since 2015, companies in the pharmaceutical sector have been faced with numerous ANSM and FDA injunctions. These all have in common a failure of the Quality Management System and/or a very significant disregard for Good Manufacturing Practices (GMP).
These regulatory requirements apply to all players in the medical field: chemical, cosmetics, medical device, CRO, and biotechnology industries.

In light of this, Bio15Pharma is committed to offering you effective and personalized services that enable you to pursue a fundamental objective: ENSURING PRODUCT QUALITY TO GUARANTEE PATIENT SAFETY

The first assignments of the founder of Bio15Pharma - Nadjim Mhoma, as Quality Engineer, Quality & Compliance Director, and then Site Quality Director, were to remedy critical situations arising from injunctions issued by the ANSM, FDA, or ANVISA to which companies were confronted, either due to a failure in their quality management system or negligence regarding good manufacturing practices. It was these experiences that led him to set up BIO15PHARMA in 2021. To be legitimate, you have to be credible, and these 14 years of experience in big pharma companies such as Sanofi, GSK, Novartis, Servier, Genzyme, Stallergenesgreer, SEQENS, and ADARE have earned him credibility with clients today.